Colowick Alan 4
4 · Principia Biopharma Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Colowick Alan
Director
Transactions
- Exercise/Conversion
Common Stock
2020-07-01$4.54/sh+7,500$34,065→ 7,500 total - Sale
Common Stock
2020-07-01$60.00/sh−7,500$450,000→ 0 total - Exercise/Conversion
Director Stock Option (right to buy)
2020-07-01−7,500→ 47,724 totalExercise: $4.54Exp: 2027-06-26→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option vested and became exercisable as to 25% of the shares subject to the option on February 16, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.